pcDNA3-Au1-mTOR-Wild type Citations (4)

Originally described in: Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer.
Sato T, Nakashima A, Guo L, Coffman K, Tamanoi F Oncogene. 2010 May 6. 29(18):2746-52. PubMed Journal

---

Articles Citing pcDNA3-Au1-mTOR-Wild type

Articles
RACK1 is an Interaction Partner of ATG5 and a Novel Regulator of Autophagy. Erbil S, Oral O, Mitou G, Kig C, Durmaz-Timucin E, Guven-Maiorov E, Gulacti F, Gokce G, Dengjel J, Sezerman OU, Gozuacik D. J Biol Chem. 2016 Jun 20. pii: jbc.M115.708081. PubMed
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma. Fan Q, Aksoy O, Wong RA, Ilkhanizadeh S, Novotny CJ, Gustafson WC, Truong AY, Cayanan G, Simonds EF, Haas-Kogan D, Phillips JJ, Nicolaides T, Okaniwa M, Shokat KM, Weiss WA. Cancer Cell. 2017 Mar 13;31(3):424-435. doi: 10.1016/j.ccell.2017.01.014. PubMed
Constitutive Activation Mutant mTOR Promote Cone Survival in Retinitis Pigmentosa Mice. Rajala A, Wang Y, Rajala RVS. Adv Exp Med Biol. 2018;1074:491-497. doi: 10.1007/978-3-319-75402-4_61. PubMed
MTOR involved in bacterial elimination against Trueperella pyogenes infection based on mice model by transcriptome and biochemical analysis. Huang T, Cui K, Song X, Jing J, Lin J, Wang X, Zhang X, Chu Y, Yue B. Vet Microbiol. 2019 Aug;235:199-208. doi: 10.1016/j.vetmic.2019.06.021. Epub 2019 Jul 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.